This article has been updated from a previous version.

NEW YORK, July 2 - The future of an R&D collaboration between Celera Genomics and stem-cell company Geron has been cast into doubt after Geron laid off roughly one-third of its staff and since both companies have refocused their research initiatives, GenomeWeb has learned.


To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.